As a risk factor for AD, chronic hypoxia upregulates HIF-1α, which decreases the activity of protein phosphatase-2A (PP2A), thereby mediating tau hyperphosphorylation with resultant cognitive dysfunction [197]. This evidence concerns the gene MAPT and Alzheimer disease.